RCC Agent Lenvatinib of Benefit in Anaplastic Thyroid Cancer

Certain genetic alterations associated with anaplastic transformation in thyroid cancer made patients sensitive to the multikinase inhibitor lenvatinib.

Source: CancerNetwork - May 10, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Thyroid Cancer Source Type: news